[1] ZHANG L Q.Research on the pathogenesis and treatment of epilepsy[J]. Journal of Medical Information(医学信息), 2021, 34(16): 44-46. [2] WHO. Epilepsy[EB/OL].(2018-02-08)[2018-10-18].http://www.who.int/zh/news-room/fact-sheets/detail/epilepsy. [3] LI D, QIN LF, LI HY.Research progress on adverse reactions caused by antiepileptic drugs[J]. Journal of Clinical Rational Drug Use(临床合理用药杂志), 2020, 13(24): 175-176. [4] ZHANG JL, ZHI YG, HU J, et al.Analysis of drug-related problems of antiepileptic drugs in adult patients with epilepsy in a hospital[J]. Chinese Journal of Drug Application and Monitoring(中国药物应用与监测), 2022, 19(1): 51-54. [5] DU Y, LIN J, SHEN J, et al.Adverse drug reactions associated with six commonly used antiepileptic drugs in southern China from 2003 to 2015[J]. BMC Pharmacol Toxicol, 2019, 20(1): 7. [6] SANKARANENI R, LACHHWANI D.Antiepileptic drugs-a review[J]. Pediatr Ann, 2015, 44(2): e36-42. [7] LÖSCHER W, POTSCHKA H, SISODIYA SM, et al. Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options[J]. Pharmacol Rev, 2020, 72(3): 606-638. [8] JIA RH, WANG XM, LI XW, et al.Hyperhomocysteinemia in epileptic patients on commonly usedantiepilepticdrugs[J]. Progress in Modern Biomedicine(现代生物医学进展), 2012, 12(9): 1665-1667. [9] SUN M, ZHOU R, WANG X, et al.Influence of different antiepileptic drugs on blood ammonia and homocysteine levels in children with epilepsy[J]. Evid Based Complement Alternat Med, 2021, 22: 5698765. [10] LIU X, MA MH, TIAN WW, et al.Investigation of clinical use of antiepileptic drugs in hospitalized patients[J]. Chinese Journal of Clinical Pharmacy(中国临床药学杂志), 2018, 27(1): 51-53. [11] QIU XY, DING SH, YANG SM.Analysis on adverse reactions reports of antiepileptic drugs in children in Baoshanarea of Yunnan in the past two years[J]. Chinese Journal of Pharmacovigilance(药物流行病学杂志), 2019, 28(7): 447-451. [12] National Bureau of Statistics. Office of the Leading Group for the Seventh National Population Census of the State Council.Announcement of the Seventh National Population Census[1](No.5)[N]. China Information Daily(中国信息报), 2021-05-12(002). [13] ZHU YC, JIN PF.Older people should avoid the risk of multimedication[J]. BaoJian Yi Yuan(保健医苑), 2023, 235(1): 13-15. [14] REN J.Analysis of clinical application and adverse reaction of antiepileptic drugs[J]. Chin J Mod Drug Appl(中国现代药物应用), 2015, 9(7): 263-264. [15] VERROTTI A, LATTANZI S, BRIGO F, et al.Pharmacodynamic interactions of antiepileptic drugs: from bench to clinical practice[J]. Epilepsy & Behavior, 2020, 104(Pt A): 106939. [16] JOSHI R, TRIPATHI M, GUPTA P, et al.Adverse effects & drug load of antiepileptic drugs in patients with epilepsy: monotherapy versus polytherapy[J]. Indian J Med Res, 2017, 145(3): 317-326. [17] DU YR, SONG QJ, SHEN JZ, et al.Analysis of 1170 cases of adverse drug reactions induced by antiepileptic drugs used in monotherapy[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(2): 101-105. [18] HUANG JY.Analysis of the effects of quality clinical pharmacy services in epilepsy patients receiving medical treatment[J]. Contemporary Medical Symposium(当代医药论丛), 2019, 17(23): 100-101. [19] CUI HZ, GUO YM, YU Q.Practice of individualized pharmaceutical care for pregnant epilepsy patients[C]. Summary of the Third Academic Symposium of the Clinical Pharmacology and Toxicology Professional Committee of Chinese Integrated Traditional and Western Medicine in 2019, 2019. [20] HUANG Q, WANG XJ, YUAN J.Experience in drug monitoring and pharmaceutical services for outpatient epilepsy patients[C]. Collection of abstracts from the 8th National Academic Annual Conference on Therapeutic Drug Monitoring, 2018. [21] DOU M, LYU WW, SUN SW, et al.Pharmacy outpatient service for the drug treatment management of epilepsy in 1 case[J]. Journal of Medical Theory and Practice(医学理论与实践), 2021, 34(21): 3807-3808. [22] ZHANG LF, YAO XL, HU XB.Impact analysis of effective intervention by clinical pharmacists on the incidenceof adverse drug reactions through rational drug use[J]. China Modern Medicine(中国当代医药), 2020, 27(35): 69-71. |